Back
Vertex Pharmaceuticals Stock Predictions

Should You Invest in this AI Marketing High-Growth Startup by April?
Invest Now & Secure Your Stake in RAD Intel
Sell
46
VRTX
Vertex Pharmaceuticals
Last Price:
$488.44
Seasonality Move:
7.72%
7 Day Trial
ALL ACCESS PASS
$
7

Missed Airbnb? Your Next Chance Could Be Sitting In Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Vertex Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Vertex Pharmaceuticals has on average historically risen by 29% based on the past 33 years of stock performance.
-
Vertex Pharmaceuticals has risen higher in 21 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
-
Is Vertex Pharmaceuticals Stock Undervalued?The current Vertex Pharmaceuticals [VRTX] share price is $485.72. The Score for VRTX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
VRTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Vertex Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Vertex Pharmaceuticals has on average historically risen by 29% based on the past 33 years of stock performance.
Vertex Pharmaceuticals Stock Rating
Sell
46
Vertex Pharmaceuticals (VRTX)
is a Sell
Is Vertex Pharmaceuticals overpriced?
-
Vertex Pharmaceuticals has risen higher in 21 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
Vertex Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vrtx.com
52-Week Data
52-Week High:
519.88
52-Week Low:
377.85
Prediction Charts
Market Cap:
124.7B
Price in USD:
485.72
Volume:
1.3M
Beta:
0.95
Technical Analysis
SMA50:
443.49
SMA100:
458.24
SMA200:
466.26
52-Wk Change:
17.94%
Stock Predictions
-
Is Vertex Pharmaceuticals stock public?Yes, Vertex Pharmaceuticals is a publicly traded company.
-
What is the Vertex Pharmaceuticals stock quote today?The Vertex Pharmaceuticals stock price is 485.72 USD today.
-
How to buy Vertex Pharmaceuticals stock online?You can buy Vertex Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Feb-13 | 454.45 | 462.58 | 465.68 | 450.60 |
Feb-14 | 462.50 | 459.00 | 469.55 | 457.36 |
Feb-18 | 455.06 | 462.11 | 467.86 | 451.99 |
Feb-19 | 463.12 | 471.76 | 472.12 | 461.91 |
Feb-20 | 474.01 | 480.33 | 481.18 | 472.80 |
Feb-21 | 481.36 | 484.24 | 487.38 | 479.69 |
Feb-25 | 480.95 | 480.35 | 486.14 | 476.26 |
Feb-26 | 479.93 | 479.10 | 484.98 | 474.24 |
Feb-27 | 475.34 | 474.50 | 486.07 | 473.51 |
Feb-28 | 479.90 | 479.79 | 484.98 | 474.01 |
Mar-3 | 477.82 | 483.31 | 490.65 | 477.73 |
Mar-4 | 485.49 | 486.22 | 490.70 | 480.11 |
Mar-5 | 485.25 | 491.64 | 495.54 | 483.54 |
Mar-6 | 490.15 | 485.72 | 491.62 | 479.78 |
Vertex Pharmaceuticals Earnings
Vertex Pharmaceuticals Earnings Report: Per Share Vertex Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Vertex Pharmaceuticals Forecast Revenue Growth
Vertex Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Vertex Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.43 per share, an increase next quarter of $0.09 per share, an increase this year of $17.58 per share, and an increase next year of $2.24 per share.
* Vertex Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.